No Products on your Comparison List.
Your basket is empty.
Find out more
Prenylcysteine is released during the degradation of prenylated proteins. Additionally we are shipping PCYOX1 Antibodies (27) and PCYOX1 Proteins (10) and many more products for this protein.
Showing 2 out of 7 products:
Elevated prenylcysteine oxidase 1 (PCYOX1) activity could help to propagate the oxidative burden of low density lipoproteins (LDLs), thus making PCYOX1 a potential pharmacological target and a new biomarker in cardiovascular disease [Review].
initial studies of the kinetic mechanism and stereospecificity of this unusual enzyme
Addition of the substrate farnesylcysteine to lipoprotein resulted in a time-dependent generation of H(2)O(2) which was stronger in very low density lipoprotein (VLDL) than in LDL or HDL, reflecting the greater protein content of PCL1 in VLDL.
Prenylcysteine is released during the degradation of prenylated proteins. PCYOX1 catalyzes the degradation of prenylcysteine to yield free cysteines and a hydrophobic isoprenoid product (Tschantz et al., 1999
, prenylcysteine oxidase
, chloride ion pump-associated 55 kDa protein
, prenylcysteine oxidase 1